Try our Advanced Search for more refined results
Life Sciences - January, 2005
31 articles
- FDA Rejects J&J Petition, OKs Duragesic Generics
- Teva Wins Appeal Over Merck's Fosamax Patent
- Brazil Renews Threat To Break Patents On HIV/AIDS Drugs
- Judge Assigns Joint Inventor To Visudyne Patent
- AstraZeneca Faces New Class-Action Suit Over Prilosec Patent Expiration
- Judge Overturns $35M Jury Award In Georgia Trademark Case
- Ranbaxy Rules Out "At-Risk" Lipitor Launch: Report
- In Blow To Barr Pharma, Appeals Court Affirms Wyeth Victory In Trade-Secrets Case
- WHO Endorses Compulsory Licensing Of Anti-Flu Patents
- Genzyme Sues TKT Over Biotech Patent In Israeli Court
- European Patent Office Upholds Angiotech's Patent For Drug-Coated Stents
- Eon Challenges Pfizer's Patents For Zithromax
- Federal Circuit Rules For Pfizer In Teva's Challenge To Zoloft Patent
- Court Refuses To Reclassify Allergan's Restasis As Non-Antibiotic
- Darby Calls For Pre-Emptive Strategies
- In Setback For Glaxo, European Court Clears Paxil Generics
- Mergen, Oxford Gene Technology Settle Patent Infringement Suit
- Trial Opens In Glaxo's Lamictal Patent Suit
- Shire Sues Impax Again Over New Adderall ANDAs
- St. Jude Medical To Pay $5M To Settle Edwards Patent Suit
- Burns Doane Hires Fish & Richardson Biotech Expert For San Diego Outpost
- U.S. Supreme Court To Hear Merck v. Integra
- Geron Wins Patent Interference Over Cloning Technology
- Judge Deals Blow To Medtronic In Case Over Heart-Stent Patents
- Judge Rules Against Teva In Case Over Generic Univasc
- Australian Medical Device Maker Sues U.S. Rival Over Cardiac Device Patents
- Kenyon Hires Manager Of Sughrue's Silicon Valley Office
- Andrx To Exit Brand Business, Focus On Generic Drugs
- Bristows Steers Global Clients Through British IP Waters
- In Policy Overhaul, India Allows Drug Patents
- In Setback For Mylan, Judge Upholds Levaquin Patent